Managing the TME to improve the efficacy of cancer therapy

MT Bilotta, A Antignani, DJ Fitzgerald - Frontiers in immunology, 2022 - frontiersin.org
The tumor microenvironment (TME) influences tumor growth, metastatic spread and
response to treatment. Often immunosuppression, mediated by the TME, impairs a beneficial …

Targeting NK-cell checkpoints for cancer immunotherapy

A Muntasell, MC Ochoa, L Cordeiro… - Current opinion in …, 2017 - Elsevier
Highlights•NK cells are cytotoxic lymphocytes with potential for cancer immunotherapy.•NK-
cell numbers and function are regulated by surface receptors and cytokines.•Inhibitory and …

The TGF-β pathway: a pharmacological target in hepatocellular carcinoma?

E Gonzalez-Sanchez, J Vaquero… - Cancers, 2021 - mdpi.com
Simple Summary Transforming Growth Factor-beta (TGF-β) signaling is crucial to maintain
tissue homeostasis. Alterations in TGF-β signaling impact tissue functions and favor the …

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model

R Piranlioglu, EM Lee, M Ouzounova, RJ Bollag… - Nature …, 2019 - nature.com
Although clinically apparent metastasis is associated with late stages of cancer
development, micro-metastatic dissemination may be an early event. However, the fate of …

Recent and future perspectives on engineering interferons and other cytokines as therapeutics

T Aung, WS Grubbe, RJ Nusbaum… - Trends in biochemical …, 2023 - cell.com
As crucial mediators and regulators of our immune system, cytokines are involved in a broad
range of biological processes and are implicated in various disease pathologies. The field of …

TGF‐β signaling in liver metastasis

DL Marvin, R Heijboer, P Ten Dijke… - Clinical and …, 2020 - Wiley Online Library
The presence of liver metastases drastically worsens the prognosis of cancer patients. The
liver is the second most prevalent metastatic site in cancer patients, but systemic therapeutic …

Advances in biomarker-guided therapy for pediatric-and adult-onset neuroinflammatory disorders: targeting chemokines/cytokines

MR Pranzatelli - Frontiers in Immunology, 2018 - frontiersin.org
The concept and recognized components of “neuroinflammation” are expanding at the
intersection of neurobiology and immunobiology. Chemokines (CKs), no longer merely …

2022 update on the scientific premise and clinical trials for IL-15 agonists as cancer immunotherapy

Y Peng, S Fu, Q Zhao - Journal of Leukocyte Biology, 2022 - academic.oup.com
Diverse cytokines and their receptors on immune cells constitute a highly complex network
in the immune system. Some therapeutic cytokines and their derivatives have been …

Hitting more birds with a stone: impact of TGF-β on ILC activity in cancer

C Fionda, H Stabile, C Cerboni, A Soriani… - Journal of Clinical …, 2020 - mdpi.com
Transforming growth factor (TGF)-β is a central immunosuppressive cytokine within tumor
microenvironment inhibiting the expansion and function of major cellular components of …

Imprime PGG enhances anti-tumor effects of tumor-targeting, anti-angiogenic, and immune checkpoint inhibitor antibodies

ASH Chan, TO Kangas, X Qiu, MT Uhlik… - Frontiers in …, 2022 - frontiersin.org
Imprime PGG (Imprime) is in late-stage clinical development as a combinatorial agent with
several therapeutic modalities. Here we present pre-clinical mechanistic data supportive of …